%20(10).jpg)
Direct Answer (Quick Summary)
Prior authorization for sublingual immunotherapy (SLIT) requires your allergist to submit clinical documentation proving medical necessity to your insurance company. The process typically takes 5–15 business days. Having the right paperwork ready—including allergy test results, failed medication history, and a treatment plan—speeds up approval significantly. Below, you will find step-by-step guidance and sample scripts to navigate this process.
Key Takeaways
- Prior authorization is a standard insurance process — It requires your doctor to document why SLIT is medically necessary before your plan covers it.
- Your allergist's office handles most of the work — But knowing the process helps you follow up effectively and avoid delays.
- Key documents needed — Allergy blood test results, history of failed or inadequate medications, and your allergist's treatment recommendation.
- Turnaround is typically 5–15 business days — Urgent requests may be processed faster.
- Denials can be appealed — If your first request is denied, your allergist can submit a peer-to-peer review or formal appeal.
- HeyAllergy helps navigate this process — Our team assists with prior authorization paperwork as part of your telemedicine allergy care.
What Is Prior Authorization?
Prior authorization (also called pre-authorization or pre-approval) is a requirement from your health insurance company. Before covering certain treatments, your insurer wants proof that the treatment is medically necessary for your specific condition. For sublingual immunotherapy (SLIT), this means your allergist must submit documentation showing that allergy drops are the appropriate treatment for you.
Not all insurance plans require prior authorization for SLIT. Some plans cover it as part of standard allergy treatment. Others may require the additional approval step. Your allergist's office will know what your specific plan requires.
Step-by-Step: Getting Prior Authorization for SLIT
Step 1: Get Diagnosed by a Board-Certified Allergist
The foundation of any prior authorization is a clear diagnosis. Schedule your consultation with a board-certified allergist. During your visit, your allergist will review your symptoms, medical history, and order an allergy blood test to identify your specific triggers. These results form the core of your prior authorization submission.
Step 2: Document Failed or Inadequate Prior Treatments
Insurance companies want to see that simpler treatments were tried first. This typically includes over-the-counter antihistamines (cetirizine, loratadine, fexofenadine), prescription nasal corticosteroids, nasal antihistamine sprays, and eye drops for ocular symptoms. Your allergist will document which medications you have tried, how long you used them, and why they did not adequately control your symptoms.
Step 3: Your Allergist Submits the Prior Authorization Request
Your allergist's office will compile and submit the following to your insurance company: the prior authorization request form (specific to your insurer), your allergy blood test results showing IgE sensitization, documentation of failed or inadequate prior medications, a letter of medical necessity explaining why SLIT is appropriate, relevant clinical guidelines supporting SLIT (such as the AAAAI/ACAAI Practice Parameters), and your proposed treatment plan including duration.
Step 4: Follow Up
After submission, the typical review period is 5–15 business days. If you have not heard back within 10 business days, call your insurance company to check the status. Use the sample script below.
Step 5: Handle a Denial (If Needed)
If your request is denied, do not give up. Your allergist can request a peer-to-peer review, where they speak directly with the insurance company's medical reviewer. Your allergist can also submit a formal written appeal with additional clinical documentation. You can file a complaint with your state's insurance commissioner if you believe the denial is unjustified.
Sample Phone Script: Calling Your Insurance Company
Representative: [Locates your file]
You: "Can you confirm that the prior authorization request from my allergist, [Doctor's Name], was received? What is the current status?"
If pending: "What is the expected timeline for a decision? Is there any additional information needed from my doctor's office?"
If denied: "Can you tell me the specific reason for the denial? What is the process for my doctor to request a peer-to-peer review or file an appeal? Can you provide the fax number and mailing address for appeal submissions?"
Before hanging up: "Can I get a reference number for this call? And your name for my records? Thank you."
Sample Phone Script: Requesting a Peer-to-Peer Review
This script is for your allergist's office to use when speaking with the insurance company's medical reviewer after a denial.
Allergist: "My patient has documented allergic rhinitis confirmed by IgE blood testing positive for [specific allergens]. They have failed adequate trials of [list medications and durations]. Their symptoms continue to significantly impact their quality of life, including [specific impacts: sleep disruption, missed work, etc.]."
Allergist: "Sublingual immunotherapy is supported by the AAAAI/ACAAI Practice Parameter Update as an effective and safe form of allergen immunotherapy. It is the appropriate next step for this patient given the failure of pharmacotherapy to provide adequate symptom control."
Allergist: "I'd like to understand the specific clinical basis for the denial so we can address any concerns."
Sample Letter of Medical Necessity Template
Patient: [Patient Name]
DOB: [Date of Birth]
Member ID: [Insurance Member ID]
Dear Medical Review Team,
I am writing to request authorization for sublingual immunotherapy (SLIT) for my patient, [Patient Name], who has been diagnosed with moderate-to-severe allergic rhinitis [and/or allergic asthma] based on clinical evaluation and laboratory testing.
Diagnosis: Allergic Rhinitis (ICD-10: J30.1) [add additional codes as applicable]
Allergy Testing Results: IgE blood panel positive for [list specific allergens, e.g., dust mites, grass pollen, tree pollen, cat dander].
Prior Treatment History: The patient has trialed the following medications without adequate symptom control: [List each medication, dose, duration, and outcome. Example: "Cetirizine 10mg daily x 6 months — partial relief with persistent nasal congestion and sleep disruption."]
Medical Necessity: Given the patient's confirmed allergic sensitization, inadequate response to pharmacotherapy, and significant impact on quality of life, sublingual immunotherapy is the medically appropriate next step. SLIT is supported by the AAAAI/ACAAI Sublingual Immunotherapy Practice Parameter Update (2017) as a safe and effective form of allergen immunotherapy.
Proposed Treatment Plan: Customized SLIT allergy drops targeting the patient's identified allergens, administered daily at home. Recommended duration: 3–5 years for lasting disease modification.
Thank you for your consideration. Please contact our office at [Phone Number] if additional information is needed.
Sincerely,
[Allergist Name], MD
Board-Certified Allergist/Immunologist
[Practice Name / HeyAllergy]
Common Reasons for Denial and How to Address Them
| Denial Reason | How to Respond |
|---|---|
| "Not medically necessary" | Provide detailed documentation of failed medications, symptom severity scores, and impact on daily life. Request peer-to-peer review. |
| "Insufficient trial of alternatives" | Document each medication tried with specific dates, doses, and reasons for discontinuation or inadequacy. |
| "SLIT not covered under plan" | Ask for the specific plan exclusion language. Some plans cover immunotherapy broadly but do not differentiate between shots and drops. Your allergist can clarify that SLIT falls under allergen immunotherapy. |
| "Missing documentation" | Confirm what is missing, resubmit promptly with all required items, and follow up within 5 business days. |
When to See an Allergist
If you are considering SLIT and wondering about insurance coverage, the first step is getting a proper evaluation. Book an appointment with a board-certified allergist if your allergy symptoms are not well controlled by OTC medications, you want to explore long-term treatment options like allergy drops, you have questions about insurance coverage for immunotherapy, you have been denied coverage and need help with an appeal, or you want a team that handles prior authorization paperwork for you.
At HeyAllergy, our clinical team assists with the prior authorization process as part of your care. Our telemedicine platform provides fast appointments with no waitlist, and we accept Medicare and most major PPO plans.
The Bottom Line
Prior authorization for SLIT may seem intimidating, but it is a manageable process when you have the right documentation and support. Your board-certified allergist handles the heavy lifting. Your role is to provide your medication history, follow up with your insurer if needed, and know your appeal rights. Do not let paperwork delay the long-term allergy relief you deserve.
What to Do Next
Start the process today. Book your online allergy consultation with a board-certified allergist—no waitlist, no referral needed. Our team will help navigate insurance and prior authorization so you can start HeyPak® allergy drops as soon as possible.
Frequently Asked Questions
Does every insurance plan require prior authorization for SLIT?
No. Some plans cover sublingual immunotherapy without prior authorization, while others require it. Your allergist's office will verify your plan's requirements when you schedule your appointment.
How long does prior authorization for allergy drops take?
Most insurance companies process prior authorization requests within 5–15 business days. Urgent requests may be reviewed faster. Following up proactively can help avoid unnecessary delays.
What if my prior authorization for SLIT is denied?
A denial is not the end. Your allergist can request a peer-to-peer review with the insurance company's medical reviewer or file a formal written appeal with additional documentation. Many initial denials are overturned on appeal.
Do I need to try allergy shots before getting approved for SLIT?
Not necessarily. Most insurance companies require documentation that first-line medications (antihistamines, nasal sprays) were inadequate. SLIT is an accepted form of allergen immunotherapy and does not always require a prior trial of allergy shots, though policies vary by insurer.
Can HeyAllergy help with my prior authorization?
Yes. HeyAllergy's clinical team assists with prior authorization submissions and insurance coordination as part of your telemedicine allergy care. We handle the paperwork so you can focus on getting better.
What documents do I need to provide for prior authorization?
Your allergist will need your allergy blood test results, a list of medications you have tried (with dates and outcomes), and your current symptom description. Your allergist's office handles creating the medical necessity letter and submitting it to your insurance company.
Author, Review and Disclaimer
Author: Krikor Manoukian, MD, FAAAAI, FACAAI — Board-Certified Allergist/Immunologist
Bio: Dr. Manoukian is a board-certified allergist/immunologist specializing in telemedicine-enabled allergy care and personalized SLIT programs. He leads HeyAllergy's clinical team and trains providers in safe immunotherapy.
Medical Review: HeyAllergy Clinical Team (Board-Certified Allergists/Immunologists)
Disclaimer: This article is educational and not a substitute for personalized medical or insurance advice. Coverage and prior authorization requirements vary by insurer and plan. Always consult your insurance company and clinician about your specific situation.
References
- AAAAI/ACAAI, Sublingual Immunotherapy Practice Parameter Update (2017). AAAAI
- Cox L, et al. Sublingual immunotherapy: a comprehensive review. Journal of Allergy and Clinical Immunology. 2006;117(5):1021-1035.
- CMS.gov: Prior Authorization Overview. Centers for Medicare and Medicaid Services.
- American Medical Association. Prior Authorization and Utilization Management Reform Principles.
